Inventors with similar research interests:
Location History:
- Pasadena, CA (US) (2002 - 2014)
- Duarte, CA (US) (2018 - 2022)
- Bainbridge Island, WA (US) (2014 - 2023)
- Bainbridge, WA (US) (2019 - 2023)
- Sierra Madre, CA (US) (2009 - 2024)
- Omaha, NE (US) (2011 - 2024)
- Seattle, WA (US) (2021 - 2024)
Company Filing History:
40 out of 87 
20 out of 639 
7 out of 119 
Years Active: 2002-2025
Title: Michael C. Jensen: Innovator in Chimeric Antigen Receptors
Introduction
Michael C. Jensen, based in Bainbridge Island, WA, is a distinguished inventor with an impressive portfolio of 57 patents. His innovative work primarily focuses on the development of chimeric antigen receptors (CARs), which are pivotal in advancing therapies for B cell malignancies.
Latest Patents
One of Jensen's latest patents includes the bispecific OR-gate chimeric antigen receptor responsive to CD20 and CD19. This invention features a CD20-OR-CD19 CAR protein construct that can trigger T-cell activation upon recognizing either CD19 or CD20, or both. The design of this bispecific CAR as a single molecule allows it to impart dual recognition capabilities to human T cells that are engineered to express it stably. Furthermore, the patent details the corresponding nucleic acids encoding this CAR and methods for its application in treating various B cell malignancies.
Career Highlights
Michael C. Jensen has made significant contributions to the field of immunotherapy, particularly while working at respected institutions such as Seattle Children's Hospital and City of Hope. His dedication to advancing cancer therapies through innovative technology has solidified his reputation within the scientific community.
Collaborations
Throughout his career, Jensen has collaborated with other prominent figures in the field, including Stanley R. Riddell and Yvonne Y. Chen. These partnerships have facilitated the advancement of groundbreaking research and the successful implementation of innovative therapies.
Conclusion
Michael C. Jensen's contributions to the development of bispecific chimeric antigen receptors represent a crucial leap forward in the treatment of B cell malignancies. His extensive patent portfolio and collaborative efforts underscore his pivotal role as an innovator in the field of medical research. As the landscape of immunotherapy continues to evolve, the impact of Jensen's work will undoubtedly resonate across the industry.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.